Gene Therapy Innovation and Manufacturing Centre (GTIMC) is pleased to announce its attendance at Advanced Therapies UK 2026, taking place on 17th and 18th March 2026 at the ExCeL London where we will be joining over 3,300 global executives, researchers, and clinicians to discuss the latest advancements in the Advanced Therapy Medicinal Products (ATMP) sector.
Members of our team attending will be:
Holly Garlick, Head of GMP
Toby Gamlen, Head of Manufacturing
Joe Cartwright, Head of Projects
Janine Kirby, GTIMC Skills and Training Lead, Professor in Neurogenetics
Rebecca Andrew, Business Development Manager
If you would like to meet with us to discuss how we can support you with AAV manufacturing, translation of your therapy from bench to clinical trial or how we address the skills gap, you are welcome to connect via the event app or LinkedIn to arrange a conversation.
Alternatively come and see us at one of the sessions:
Holly Garlick will be speaking on the panel: "Harnessing Technological Innovation to Optimise Supply Chain and Logistics in Advanced Therapies" taking place at 14:55 GMT on Tuesday 17th March 2026.
Toby Gamlen will be speaking on the panel: "Exploring the Evolving Landscape of Viral Vector Manufacturing" taking place at 17:30 GMT on Tuesday 17th March 2026.
Janine Kirby will be presenting "Development of skills and training resources: Insight from the Innovation Hub for Gene Therapy" at 11:50 GMT on Wednesday 18th March 2026.
We look forward to meeting with our partners and new collaborators to discuss how together we can bring life-changing therapies to patients faster. Tickets can be obtained from the Advanced Therapies website using the discount code UOS20.